文献速递慢阻肺呼吸道感染

流感疫苗接种对COPD患者住院及重症结局的效果

Effectiveness of Influenza Vaccination on Hospitalizations and Risk Factors for Severe Outcomes in Hospitalized Patients With COPD.
PubMed 文献 · Chest · 2019-01-01

基于2011-2015年全国前瞻性多中心队列中4,755例因急性呼吸道疾病住院的COPD患者,采用检测阴性设计分析显示,接种流感疫苗使流感相关住院减少38%。高龄、心脏合并症、长期护理机构居住和家庭氧疗是死亡风险因素。

要点

  • 接种流感疫苗可使COPD患者流感相关住院减少38%。
  • COPD患者流感阳性者死亡率与危重症比例显著高于阴性者。
  • 年龄>75岁、心脏合并症、长期护理居住和家庭氧疗增加死亡风险。

核心结论

  • 流感疫苗接种显著减少COPD患者流感相关住院。
  • 提高接种率及早期使用抗病毒药物可减少住院和危重症并改善医疗成本。

研究设计与样本

  • 全国前瞻性多中心队列研究,纳入2011-2015年因急性呼吸道疾病或加重住院的COPD患者。
  • 所有患者接受鼻咽拭子PCR流感检测,采用检测阴性设计的多因素logistic回归估计疫苗效果。
  • 4,755例住院COPD患者中4,198例(88.3%)疫苗接种状态已知并纳入分析。

主要发现

  • 调整分析显示,接种组较未接种组流感相关住院减少38%。
  • 流感阳性患者死亡风险因素:年龄>75岁(OR 3.7,95%CI 0.4-30.3)、心脏合并症(OR 2.0,95%CI 1.3-3.2)、长期护理机构居住(OR 2.6,95%CI 1.5-4.5)、家庭氧疗(OR 2.9,95%CI 1.6-5.1)。

临床怎么用

  • 对住院COPD患者应评估流感疫苗接种状态并推荐接种。
  • COPD患者流感阳性时需关注高龄、心脏合并症、长期护理居住和家庭氧疗等高死亡风险因素。
  • 可考虑对COPD患者早期使用抗病毒药物以降低住院和危重症风险。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The effectiveness of influenza vaccination in reducing influenza-related hospitalizations among patients with COPD is not well described, and influenza vaccination uptake remains suboptimal. METHODS: Data were analyzed from a national, prospective, multicenter cohort study including patients with COPD, hospitalized with any acute respiratory illness or exacerbation between 2011 and 2015. All patients underwent nasopharyngeal swab screening with polymerase chain reaction (PCR) testing for influenza. The primary outcome was an influenza-related hospitalization. We identified influenza-positive cases and negative control subjects and used multivariable logistic regression with a standard test-negative design to estimate the vaccine effectiveness for preventing influenza-related hospitalizations. RESULTS: Among 4,755 hospitalized patients with COPD, 4,198 (88.3%) patients with known vaccination status were analyzed. The adjusted analysis showed a 38% reduction in influenza-related hospitalizations in vaccinated vs unvaccinated individuals. Influenza-positive patients (n = 1,833 [38.5%]) experienced higher crude mortality (9.7% vs 7.9%; P = .047) and critical illness (17.2% vs 12.1%; P < .001) compared with influenza-negative patients. Risk factors for mortality in influenza-positive patients included age > 75 years (OR, 3.7 [95% CI, 0.4-30.3]), cardiac comorbidity (OR, 2.0 [95% CI, 1.3-3.2]), residence in long-term care (OR, 2.6 [95% CI, 1.5-4.5]), and home oxygen use (OR, 2.9 [95% CI, 1.6-5.1]). CONCLUSIONS: Influenza vaccination significantly reduced influenza-related hospitalization among patients with COPD. Initiatives to increase vaccination uptake and early use of antiviral agents among patients with COPD could reduce influenza-related hospitalization and critical illness and improve health-care costs in this vulnerable population. TRIAL REGISTRY: ClinicalTrials.govNo.:NCT01517191; URL www.clinicaltrials.gov.

来源:Chest,查看原文。版权归原作者所有。

引用

  1. Mulpuru S, Li L, Ye L, et al. Effectiveness of Influenza Vaccination on Hospitalizations and Risk Factors for Severe Outcomes in Hospitalized Patients With COPD. Chest. 2019. PMID: 30616737. doi:10.1016/j.chest.2018.10.044

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。